Attached files
file | filename |
---|---|
10-K - FORM 10-K - Riot Blockchain, Inc. | appy_10k.htm |
EX-32 - EXHIBIT 32 - Riot Blockchain, Inc. | ex32.htm |
EX-10.6 - EXHIBIT 10.6 - Riot Blockchain, Inc. | ex10x6.htm |
EX-31.2 - EXHIBIT 31.2 - Riot Blockchain, Inc. | ex31x2.htm |
EX-31.1 - EXHIBIT 31.1 - Riot Blockchain, Inc. | ex31x1.htm |
EX-23 - EXHIBIT 23 - Riot Blockchain, Inc. | ex23x1.htm |
EX-10.13 - EXHIBIT 10.13 - Riot Blockchain, Inc. | ex10x13.htm |
EX-10.15 - EXHIBIT 10.15 - Riot Blockchain, Inc. | ex10x15.htm |
EX-10.12 - EXHIBIT 10.12 - Riot Blockchain, Inc. | ex10x12.htm |
EX-10.14 - EXHIBIT 10.14 - Riot Blockchain, Inc. | ex10x14.htm |
EX-10.1.1 - EXHIBIT 10.1.1 - Riot Blockchain, Inc. | ex10x1x1.htm |
EX-10.4.1 - EXHIBIT 10.4.1 - Riot Blockchain, Inc. | ex10x4x1.htm |
Exhibit 10.1.2
ASPENBIO
PHARMA, INC.
AMENDMENT
TO 2002 STOCK INCENTIVE PLAN
EFFECTIVE
NOVEMBER 20, 2009
This
Amendment No. 2, dated and effective November 20, 2009 (the “Amendment”) is an
amendment to the 2002 Stock Incentive Plan, as amended and restated on June 1,
2007 (the “Plan”) of AspenBio Pharma, Inc., a Colorado corporation (the
“Company”). All capitalized terms used in this Amendment without
definition have the meanings set forth in the Plan.
WHEREAS,
Section 20(a) authorizes the Board of Directors of the Company to make
amendments to the Plan, subject to shareholder approval as required by law or
agreement.
WHEREAS,
on September 18, 2009, the Board approved an amendment to the Plan to increase
the number of shares available for awards under the Plan from 4,600,000 to
6,100,000, and submitted such amendment to the Company’s shareholders for
approval at the annual meeting of shareholders held on November 20,
2009.
WHEREAS,
on November 20, 2009, the shareholders approved the foregoing amendment to the
Plan.
NOW,
THEREFORE, intending to be legally bound, and in accordance with the approvals
set forth in the WHEREAS clauses, which are incorporated by reference into this
Amendment, the Company amends the Plan as follows:
1. Section
4 of the Plan is deleted in it entirety and is replaced by the
following:
“4. The Common
Stock. The Board is authorized to appropriate, issue and sell
for the purposes of the Plan, and the Option Committee is authorized to grant
Options and Rights to Purchase with respect to, a total number, not in excess of
6,100,000 shares of Common Stock, either treasury or authorized but unissued or
the number and kind of shares of stock or other securities which in accordance
with Section 16 of this Plan shall be substituted for the 6,100,000 shares or
into which such 6,100,000 shares shall be adjusted. All or any unsold
shares subject to an Option or Right to Purchase that for any reason expires or
otherwise terminates may again be made subject to Options or Rights to Purchase
under the Plan. No person may be granted Options or Rights to
Purchase under this Plan covering in excess of an aggregate of 500,000 Option
Shares and shares of Restricted Stock in any calendar year, subject to
adjustments in connection with Section 16 of this Plan.”
2. Except
as amended by this Amendment, the Plan continues in full force and
effect.
3. In
the event of a conflict between this Amendment and the Plan, this Amendment
shall govern.